Assessment of dose inhomogeneities in clinical practice by film dosimetry

Radiotherapy and Oncology

Volumn 49, Issue 3, 1998, Pages 287-294

  Weltens, Caroline ^a   Huyskens, Dominique ^a   Dutreix, Andrée ^a   Van Der Schueren, Emmanuel ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Breast; Dose; Film dosimetry; Head and neck; Quality assurance; Radiotherapy

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL PRACTICE; FILM DOSIMETER; HEAD AND NECK CARCINOMA; HUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; RADIATION DOSE;

EID: 0032427688     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00138-8     Document Type: Article

References (27)

1. [1] Boellaard R, Essers M, Van Herk M, Mijnheer B. New method to obtain the midplane dose using portal in vivo dosimetry. Int. J. Radiat. Oncol. Biol. Phys. 1998;41:465-474.
2. [2] Boellaard R, Van Herk M, Uiterwaal H, Mijnheer B. Two-dimensional exit dosimetry using a liquid-filled electronic portal imaging device and a convolution model. Ratiother. Oncol. 1997;44:149-157.
3. [3] Cheng C, Das I, Stea B. The effect of the number of computed tomographic slices or dose distributions and evaluation of treatment planning systems for radiation therapy of intact breast. Phys. Med. Biol. 1994;30:193-195.
4. [4] Ebert M, Kron T. Portal films for relative exit dose determinations. Australas. Phys. Eng. Sci. Med. 1994;17:71-78.
5. [5] Essers M, Boellaard R, Van Herk M, Lanson H, Mijnheer B. Transmisison dosimetry with a liquid-filled electronic portal imaging device, Int. J. Radiat. Oncol. Biol. Phys. 1996;34:931-941.
6. [6] Evans P, Hansen P, Mayles W, Swindell W, Torr M, Yarnold J. Design of compensators for breast radiotherapy using electronic portal imaging. Radiother. Oncol. 1995;37:41-54.
7. [7] Fiorino C, Del Vecchio A, Gattaneo G, et al. Exit dose measurements by portal filn dosimetry. Radiother. Oncol. 1993;29:336-340.
8. [8] Garavaglia G, Porepp C, Jezefowsky M. Improved dose distribution in conservative breast irradiation. Radiother. Oncol. 1991;22:245-247.
9. [9] Huyskens D, Van Dam J, Dutreix A. Midplane dose determination using in vivo dose measurements in combination with portal imaging. Phys. Med. Biol. 1994;39:1089-1101.
10. [10] Jaffray D, Bassista F, Fenster A, Munro P. X-ray scatter in megavoltage transmission radiography: physical characteristics and influence on image quality. Med. Phys. 1994;21:54-60.
11. [11] Kirby M, Williams P. The use of an electronic portal imaging device for exit dosimetry and quality control measurements. Int. J. Radiat. Oncol. Biol. Phys. 1995;31:593-603.
12. [12] Leunens G, Van Dam J, Dutreix A, van der Schueren E. Quality assurance in radiotherapy by in vivo dosimetry 1. Entrance dose measurements, a reliable procedure. Radiother. Oncol. 1990;17:141-151.
13. [13] Leunens G, Van Dam J, Dutreix A, van der Schueren E. Quality assurance in radiotherapy by in vivo dosimetry 2. Determination of the target absorbed dose. Radiother. Oncol. 1990;19:73-87.
14. [14] Leunens G, Verstraete J, Dutreix A, van der Schueren E. Assessment of dose inhomogeneity at target level by in vivo dosimetry: can the recommended 5% accuracy in the dose delivered to the target volume be fulfilled in daily practice?. Radiother. Oncol. 1992;25:242-250.
15. [15] LoSasso T, Chui C, Kutcher G, Leibel S, Fuks Z, Ling C. The use of a multileaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. Int. J. Radiat. Biol. Phys. 1993;25:161-170.
16. [16] Mayles W, Yarnold J, Webb S. Improved dose homogeneity in the breast using tissue compensators. Radiother. Oncol. 1991;22:248-251.
17. [17] Novotny J, Gomola Izewska J, Huyskens D, Dutreix A. External audit of photon beams by mailed dosimetry: feasability study. Phys. Med. Biol. 1997;42:1277-1288.
18. [18] Roback D, Gerbi B. Evaluation of electronic portal imaging device for missing tissue compensator design and verification. Med. Phys. 1995;22:2029-2033.
19. [19] Swindell W, Evans P. Scattered radiation in portal images: a Monte Carlo simulation and a simple physical model. Med. Phys. 1996;23:63-73.
20. [20] Swindell W, Morton E, Evans P, Lewis D. The design of megavoltage projection imaging systems: some theoretical aspects. Med. Phys. 1991;18:855-866.
21. [21] Van Bree N, Idzes M, Huizenga H, Mijnheer B. Film dosimetry for radiotherapy treatment planning verification of a 6 MV tangential breast irradiation. Radiother. Oncol. 1994;31:251-255.
22. [22] Van Dam J, Vaerman C, Blankaert N, Leunens G, Dutreix A, van der Schueren E. Are port films reliable for in vivo exit dose measurements?. Radiother. Oncol. 1993;30:167-170.
23. [23] Weltens C, Van Dam J, Leunens G, Dutreix A, van der Schueren E. Reliability of clinical port films to measure dose inhomogeneities in radiotherapy for head and neck tumours. Radiother. Oncol. 1993;30:167-170.
24. [24] Williamson J, Khan F, Sharma S. Film dosimetry of megavoltage photon beams: a practical method of isodensity to isodose curve conversion. Med. Phys. 1981;8:94-98.
25. [25] Wong J, Slessinger E, Hermess R, Offult C, Roy T, Vannier M. Portal dose images I: quantitative treatment plan verification. Int. J. Radiat. Oncol. Biol. Phys. 1990;18:1455-1463.
26. [26] Zhu Y, Jiang X, Van Dyk J. Portal imaging using a liquid ion chamber matrix: dose response studies. Med. Phys. 1995;22:1101-1106.
27. [27] Zierhut D, Flentje M, Frank C, Oetzel D, Wannenmacher M. Conservative treatment of breast cancer: modifier irradiation technique for women with large breasts. Radiother. Oncol. 1994;31:256-261.